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Abstract

Key Points

IMPORTANCE The indication (reason for use) for a medication is rarely included on prescriptions
despite repeated recommendations to do so. One barrier has been the way existing electronic
prescribing systems have been designed.

Question Is a redesigned electronic
prescribing workflow to better support
the incorporation of the indication in the
outpatient prescribing process

OBJECTIVE To evaluate, in comparison with the prescribing modules of 2 leading electronic health
record prescribing systems, the efficiency, error rate, and satisfaction with a new computerized

associated with reduced errors and
improved clinician experience?

provider order entry prototype for the outpatient setting that allows clinicians to initiate prescribing

Findings This quality improvement

using the indication.

study compared an indications-based
electronic prescribing prototype with

DESIGN, SETTING, AND PARTICIPANTS This quality improvement study used usability tests

that of 2 leading electronic health record

requiring internal medicine physicians, residents, and physician assistants to enter prescriptions

vendors and found that the usability of

electronically, including indication, for 8 clinical scenarios. The tool order assignments were

the prototype system substantially

randomized and prescribers were asked to use the prototype for 4 of the scenarios and their usual

outperformed both vendors’ prescribing

system for the other 4. Time on task, number of clicks, and order details were captured. User

systems in terms of efficiency, error rate,

satisfaction was measured using posttask ratings and a validated system usability scale. The study

and satisfaction.

participants practiced in 2 health systems’ outpatient practices. Usability tests were conducted
between April and October of 2017.

Meaning Reengineering prescribing to
start with the drug indication allowed
indications to be captured in an easy and

MAIN OUTCOMES AND MEASURES Usability (efficiency, error rate, and satisfaction) of indicationsbased computerized provider order entry prototype vs the electronic prescribing interface of 2
electronic health record vendors.

useful way and may be associated with
saved time and effort, reduced errors,
and increased clinician satisfaction.

RESULTS Thirty-two participants (17 attending physicians, 13 residents, and 2 physician assistants)
used the prototype to complete 256 usability test scenarios. The mean (SD) time on task was 1.78
(1.17) minutes. For the 20 participants who used vendor 1’s system, it took a mean (SD) of 3.37 (1.90)
minutes to complete a prescription, and for the 12 participants using vendor 2’s system, it took a

+ Supplemental content
Author affiliations and article information are
listed at the end of this article.

mean (SD) of 2.93 (1.52) minutes. Across all scenarios, when comparing number of clicks, for those
participants using the prototype and vendor 1, there was a statistically significant difference from the
mean (SD) number of clicks needed (18.39 [12.62] vs 46.50 [27.29]; difference, 28.11; 95% CI, 21.4734.75; P < .001). For those using the prototype and vendor 2, there was also a statistically significant
difference in number of clicks (20.10 [11.52] vs 38.25 [19.77]; difference, 18.14; 95% CI, 11.59-24.70;
P < .001). A blinded review of the order details revealed medication errors (eg, drug-allergy
interactions) in 38 of 128 prescribing sessions using a vendor system vs 7 of 128 with the prototype.
(continued)
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Abstract (continued)

CONCLUSIONS AND RELEVANCE Reengineering prescribing to start with the drug indication
allowed indications to be captured in an easy and useful way, which may be associated with saved
time and effort, reduced medication errors, and increased clinician satisfaction.
JAMA Network Open. 2019;2(3):e191514. doi:10.1001/jamanetworkopen.2019.1514

Introduction
For nearly 4 decades, multiple medication safety organizations such as the National Coordinating
Council for Medication Error Reporting and Prevention, the National Association of Boards of
Pharmacy, and the National Council for Prescription Drug Programs have recommended including
the indication (reason for the medication) on written prescriptions and medication bottle labels for
safer and more understandable prescriptions.1-5 However, for a variety of reasons, progress has been
slow in including the indication in medication orders.6,7 Based on a literature review and stakeholder
input, we identified barriers preventing clinicians from including the drug indication on their
outpatient electronic prescriptions, including lack of time for this added step, poor software design
and integration of indications into ordering software and workflow, confidentiality concerns, and
uncertainty of the value of this extra step.7,8 Nonetheless, when surveyed, physicians, pharmacists,
and patients overwhelmingly favor inclusion of the indication in the prescription.3,9
To address this gap, we conducted a 4-year project funded by the Agency for Healthcare
Research and Quality to help accelerate progress in incorporation of indications into prescribing. We
found that in current systems there are a variety of ways to add indications to prescriptions, but
these required clinicians to either manually enter free text or select various precoded indications. To
avoid this extra step, we conceptualized a fundamentally different way of composing electronic
prescriptions—one that could both capture the indication and also support clinicians in choosing the
most appropriate drug. Properly designed, the clinician, rather than entering a drug, would instead
enter an indication or choose one from the problem list. The reengineered computerized provider
order entry (CPOE) system would suggest recommended treatment as well as capture indication. We
hypothesized that this approach would make identifying and ordering the right drug faster, easier,
and safer.
We designed a prescribing prototype following a user-centered design process involving
contextual inquiry sessions, participatory design, usability roundtables, formative usability testing
with think-aloud protocols, and iterative refinement of the prototype. We then conducted
summative usability testing comparing the prototype to the prescribing interface of 2 leading
commercial electronic health record (EHR) systems using 8 typical primary care prescribing
scenarios. Our aim was to compare the efficiency, error rate, and satisfaction of the 3 systems using a
mixed-methods qualitative and quantitative approach.

Methods
This quality improvement study used usability testing to compare a prototype indications-based
prescribing interface to that of 2 vendor EHRs. While it was not a quality improvement intervention,
we followed the Standards for Quality Improvement Reporting Excellence (SQUIRE) reporting guideline
when applicable.

Prototype Description
Following a period of user-centered design activities focused on understanding the value, barriers,
desired features, and user requirements, we designed an indications-based prescribing CPOE
prototype. It was designed with the option to enter a prescription by either searching for an
indication or selecting a problem from the problem list. A key feature is the list of drugs of choice, or
JAMA Network Open. 2019;2(3):e191514. doi:10.1001/jamanetworkopen.2019.1514 (Reprinted)
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best-practice options, based on the selected indication. This patient-specific list of drug choices was
customized for sample test patient scenarios based on evidence-based guidelines, US Food and Drug
Administration labeled and nonlabeled indications, insurance formulary requirements, and patientspecific factors such as contraindications due to drugs, allergies or intolerance, or renal function. The
medication options for any given indication were presented as suggested choice (in green),
alternative (in yellow), or not recommended (in red) (Figure 1). The prototype also presented
recommended initial dosing, frequency, and other order details based on the indication chosen and
patient factors that would influence dosing, such as weight or renal function. Clinicians also had the
option to search for and enter the drug directly (ie, as typical in CPOE). Immediately following a
search for a specific drug, clinicians were required to select an indication from a list of drug-specific
indications to associate with the order. Our prototype automatically displayed the indication on the
prescription instructions, except for potentially sensitive conditions such as psychiatric diagnoses
or sexually transmitted infections, for which the default was to suppress the indication. We allowed
clinicians to change the default choice of including the indication in the instructions by presenting it
as a check box on the order details screen (eFigure in the Supplement). The prototype was designed
to support multidrug treatment regimens and multiple indications if warranted.

Usability Testing
Recruitment
Eligible participants included internal medicine faculty, residents, and physician assistants who were
using either Epic or Cerner systems to prescribe electronically in the outpatient setting. A
convenience sample of eligible participants from Partners HealthCare and University of Illinois
Hospital were emailed a recruitment letter and frequently asked questions document by the principal
investigator or site investigator. Informed consent was obtained verbally prior to the usability test.
This study was approved by the Partners HealthCare and the University of Illinois at Chicago human
subjects research committees. Usability tests were conducted between April and October of 2017.
Clinical Scenarios
Eight clinical scenarios were developed by the project pharmacists (A.S. and M.G.A.) in collaboration
with additional clinicians and subject matter experts on our research team (A.W., T.E., D.W.B., G.D.S.,
and W.L.G.) (eTables 1-8 in the Supplement). Medication recommendation choices were identified by
review of practice guidelines for each clinical condition in the 8 scenarios. The scenarios included a

Figure 1. Screenshot From the Indications-Based Prescribing Prototype of the Gonorrhea Case Scenario

A prescriber enters the indication in the search bar (or
selects it from a preexisting problem list—not shown
on the screen). The prototype then suggests drugs of
choice with alternatives and drugs that are not
recommended based on patient factors (eg, allergies),
insurance formulary requirements, and evidencebased guidelines. After a drug is selected, the order
details screen appears with most fields prepopulated
with default options for dosing and frequency based
on the indication and patient factors. Completing the
order details adds the ordered drugs to the RxCart for
final confirmation (next screen not shown here).
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combination of common primary care ambulatory problems, such as poorly controlled hypertension,
migraine prophylaxis, gout flare, and newly diagnosed diabetes. In addition, 2 scenarios, gonorrhea
and Helicobacter pylori infection, required multimedication combinations with specific dosing
schedules and treatment durations. Each scenario was designed to consider various challenges that
clinicians often encounter at the time of prescribing, such as patient-specific factors that affect
treatment choices (allergies, renal impairment, and comorbidities). We also included 2 scenarios
designed to provoke common look-alike or sound-alike medication errors: hydroxyzine vs
hydralazine and risperidone vs ropinirole.10 To make the medication ordering as realistic as possible,
case scenarios included relevant clinical data (eg, renal and liver function panels and glycated
hemoglobin levels) that may influence the drug options that would be appropriate for the patient.
Test patients were created in the prototype system and each vendor system so that the medical
records matched the clinical information supporting the scenarios.
Test Procedures
Each hour-long test session was held either in a clinical office or conference room. We deployed
Morae usability software version 3.3.4 (Techsmith) on a laptop with a wireless mouse to record the
sessions.11 An observer and note-taker (I.N.) attended each session along with the moderator
(P.M.G.). Participants completed 4 scenarios with the prototype system and 4 scenarios with their
usual commercial EHR. Participants were asked to complete the following task for each scenario:
“Review the patient’s history and order the appropriate medication(s) for this patient. Please include
the indication on the prescription for the pharmacist and patient (unless you have concerns about
sensitive information).” We randomly alternated the CPOE system and the 4 scenarios assigned to
participants to avoid ordering and sequential difficulty effects. Participants were provided with a
2-minute demonstration of the prototype system before beginning the tasks and were instructed to
use their vendor system as they normally would. Participants were provided with no additional
requirements or instruction in either the prototype system or the vendor system on using any
specific method to include the indication. At study completion, participants received a $50 gift card.
Usability Metrics
To capture time on task for each scenario, the moderator selected the appropriate patient record in
the system and brought the participant to a consistent starting point in both the prototype and
vendor systems, although participants could navigate away from this screen once they began. The
start time for each task began when the participant took the mouse and began to navigate. The task
ended when the participant successfully completed the task or informed us that they were done
with the orders for the scenario.
We recorded medications prescribed during each scenario and calculated an error rate based on an
independent review of each order by 2 pharmacists. In cases in which the pharmacists disagreed, this
was adjudicated by an internal medicine physician. The pharmacists and physician were blinded to which
system was used when determining whether the medication order was an error. We also recorded
whether the participants added the indication to the prescription for each scenario. In the prototype, the
indication was automatically captured when initiating the order, whereas in the vendor systems, the
participant could either enter it using free text in the patient prescription instructions or check
prespecified fields available in the vendor system. We did not include the gonorrhea scenario in this
analysis owing to the sensitive nature of the condition. We also recorded whether participants used
outside reference resources for additional information during each scenario.
The single ease question (SEQ) was administered at the completion of each scenario.12
Participants were asked to respond to the question, “Overall, how difficult or easy was this task to
complete?” on a scale from 1 to 7 with 1 indicating it was very easy and 7 indicating it was very
difficult. Average SEQ ratings were calculated using data from participants who used the same CPOE
system (prototype, vendor 1, or vendor 2) to complete a given scenario. Participants completed an
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overall system usability scale for the prototype at the end of the test session.13,14 The total system
usability scale was averaged across all participants.

Statistical Analysis
Data analysis was done using SAS statistical software version 9.3 (SAS Institute).15 We used a MannWhitney U test to compare the prototype to each vendor system on efficiency and ease of use for
each individual scenario. We did a pooled analysis using t tests to compare the overall mean time on
task, clicks, and SEQ rating for the prototype and each vendor system across all scenarios. We used χ2
tests to analyze the proportion data on access to outside reference source and prescribing errors.16
A 2-sided P value less than .05 was considered statistically significant.

Results
Overall, 17 faculty, 13 residents, and 2 physician assistants completed the usability tests, entering
medications for a total of 256 test scenarios.17,18 All 32 participants used the prototype system; of this
group 20 completed tasks using vendor 1’s system and 12 used vendor 2’s system. Most participants
had more than 2 years of experience with their current EHR system and 82% reported having an
intermediate or higher level of skill with technology (Table 1).

Efficiency
Across all 32 participants, the mean (SD) time on task to complete a medication order using the
prototype was 1.78 (1.17) minutes. Participants using vendor 1 had a mean (SD) time on task of 3.37
(1.90) minutes and those using vendor 2 had a mean (SD) time on task of 2.93 (1.52) minutes. When
comparing the participants who used both the prototype and vendor 1, ordering with the prototype
was significantly faster for 4 of the scenarios. For the participants who used vendor 2, the prototype
was significantly faster for 2 scenarios (Figure 2). When we pooled the data across all the scenarios,
the mean time for the prototype was significantly faster than either of the vendor systems (Figure 2).
The mean (SD) number of clicks to complete a scenario in the prototype was 19.0 (12.2). For
those using the prototype and vendor 1, there was a statistically significant difference from the mean

Table 1. Characteristics of 32 Participants
Characteristic

No. (%)

Clinical role
Attending physician

17 (53)

Physician assistant

2 (6)

Resident (second, third, or fourth year)

13 (41)

Time using current system, y
<2

5 (16)

2-4

17 (53)

5-10

6 (19)

>10

4 (13)

Level of skill with technology
Novice

1 (3)

Novice-intermediate

2 (6)

Intermediate

15 (47)

Intermediate-expert

5 (16)

Expert

9 (28)

Do you use indications with Epic or Cerner now?
Yes, link to diagnosis

7 (22)

For specific reasons, but not everything

8 (25)

Sometimes

7 (22)

No

10 (31)
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(SD) number of clicks needed pooled across all scenarios (18.39 [12.62] vs 46.50 [27.29]; difference,
28.11; 95% CI, 21.47-34.75; P < .001). For those using the prototype and vendor 2, there was also a
statistically significant difference in number of clicks across scenarios (20.10 [11.52] vs. 38.25 [19.77];
difference, 18.14; 95% CI, 11.59-24.70; P < .001). The difference in the number of clicks for those
participants using both the prototype and vendor 1 was statistically significant for all scenarios but
itching. There was a statistically significant difference in the number of clicks when comparing the
prototype with vendor 2 for 6 of the 8 scenarios (Figure 2).
Overall, for the 8 scenarios, 28.8% of participants (23 of 80) accessed an outside reference
source for additional information during the ordering task when using the prototype and 58.8% of
participants (47 of 80) accessed an outside reference when using vendor 1 (difference, 30.00%;
95% CI, 15.35%-44.65%; P < .001). Moreover, there was also a statistically significant difference
between the participants who sought an outside reference source using the prototype vs vendor 2
(31.3% [15 of 48] vs 56.3% [27 of 48]; difference, 25.00%; 95% CI, 5.79%-44.21%; P = .01)
(Figure 3).

Error Rate
Across all participants, 7 of 128 (5.5%) prescribing orders using the prototype were classified as
errors compared with 38 of 128 (29.7%) with a vendor system (difference, 24.22%; 95% CI, 15.38%33.06%; P < .001). Look-alike or sound-alike errors occurred in 0.8% [1 of 128] of orders in the
prototype, 2.5% [2 of 80] in vendor 1, and 2.1% [1 of 48] in vendor 2; these differences were not
statistically significant. Reasons that an order was considered erroneous included an incorrect route,
frequency, duration, or dose as well as instances in which part of a multidrug treatment was missing
(eTable 9 in the Supplement). As designed, the prototype automatically included the indication on
the order 100% of the time, excluding the gonorrhea scenario. Orders entered electronically using
vendor 1’s CPOE included the indication 61% of the time, while those entered using vendor 2’s CPOE
included the indication 62% of the time.

Figure 2. Usability Test Results of Time on Task and Clicks
A Mean time on task

Prototype

Vendor 1

Vendor 2

8
a

Mean Time, min

7

a

6

a

a

a

5

a

4

b

b

3
2
1
0

Migraine

Gout

Gonorrhea

H pylori

Hypertension Diabetes

Restless Legs

Itching

Combined

Condition
B

Mean number of clicks per task
100

b

a

a
b

80

a

Clicks, No.

a

60

b

a

b

a

b
b

a

a

b

40
20
0

Migraine

Gout

Gonorrhea

H pylori

Hypertension Diabetes

Restless Legs

Itching

Combined

Condition
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Satisfaction
The mean (SD) response to the SEQ was 1.73 (0.97) across all scenarios on the prototype, while the
mean (SD) rating was 3.70 (1.77) for vendor 1 and 2.75 (1.39) for vendor 2. For the participants who
used the prototype and vendor 1, the SEQ rating for the prototype was higher with a statistically
significant result for all but 1 scenario, itching. For the participants who used the prototype and
vendor 2, the prototype was more highly rated, although only the H pylori scenario rating showed a
statistically significant result (Table 2). The mean (SD) system usability scale score for the prototype
across all participants in the study was 89.7 (9.37), which is rated to be excellent in comparison with
a wide range of other applications.19

Discussion
Despite the steady increase in use of EHRs in the United States, clinicians remain frustrated with
many aspects of design and workflow, including medication ordering and medication-related
decision supports.20-23 In addition, current systems do little to facilitate adding indications into
prescription orders, something that has been recommended by pharmacists and safety experts for
several decades.1,2,4,5 Working with very modest resources during a 1-year period of usability
research, prototyping, and development, we designed an innovative CPOE prototype that changes
the way prescribers order drugs by offering the option of starting with the indication, thereby
permitting the computer to suggest optimal drug regimen choices. We found this approach
outperformed 2 leading vendor systems’ electronic prescribing modules on all scenarios in aggregate
in terms of efficiency, error reduction, and satisfaction. Despite minimal training on the prototype,
participants completed tasks in roughly half the time and entry clicks when ordering with the
prototype compared with both vendor systems. These time savings have major clinical implications,

Figure 3. Usability Test Results of Access to Outside Reference Source
Prototype

Vendor 1

Vendor 2

100

Participants, %

80
60
40
20
0

Migraine

Gout

Gonorrhea

H pylori

Hypertension Diabetes

Restless Legs

Itching

Combined

Condition

The percentage of participants who accessed an
outside reference source during the ordering tasks is
shown for each diagnosis for the prototype, vendor 1,
and vendor 2. H pylori indicates Helicobacter pylori.

Table 2. Responses to Single Ease Question for Each Scenarioa
Mean (SD)
Site 1 (n = 20)

Site 2 (n = 12)

Scenario

Prototype

Vendor 1

Prototype

Vendor 2

Migraine

1.80 (0.79)

3.90 (1.45)b

2.00 (1.10)

2.50 (0.84)

Gout

1.90 (1.20)

3.50 (1.84)c

1.50 (0.55)

2.83 (1.83)

Gonorrhea

1.30 (0.67)

4.10 (1.66)b

2.00 (0.89)

2.83 (0.98)

Helicobacter pylori

1.80 (1.03)

4.60 (1.58)b

1.33 (0.82)

3.83 (1.60)b

Hypertension

1.10 (0.32)

b

2.50 (1.27)

1.67 (1.21)

2.17 (0.75)

Diabetes

1.50 (0.53)

3.90 (2.08)b

1.50 (0.84)

2.17 (1.33)

Restless legs

1.70 (1.06)

3.50 (1.84)b

2.67 (1.37)

2.67 (0.82)

Itching

2.00 (0.82)

3.60 (2.12)

2.33 (1.75)

Combined

1.64 (0.84)

3.70 (1.77)b

1.88 (1.12)

a

Participants were asked after each task, “Overall,
how difficult or easy was the task to complete?”
Responses were on a 7-point rating scale with 1
indicating that the task was very easy and 7
indicating that it was very difficult.

3.00 (2.28)

b

Significant at P < .01.

2.75 (1.39)b

c

Significant at P < .05.

JAMA Network Open. 2019;2(3):e191514. doi:10.1001/jamanetworkopen.2019.1514 (Reprinted)

Downloaded From: https://jamanetwork.com/ by a Washington University - St Louis User on 03/15/2020

March 29, 2019

7/11

JAMA Network Open | Health Informatics

Comparison of Indications-Based Prescribing vs Existing Prescribing Systems

as ordering a medication is one of the most frequent tasks performed in clinical encounters. In
addition, orders generated with the prototype included the indication 100% of the time (excluding
the gonorrhea scenario) and had fewer medication errors than those placed in the vendor systems.
The prototype offers several interface design features in alignment with human factors and
usability principles that help explain our findings. To better align with a clinician’s thought process,
the prototype was organized with a focus on problem-based workflow. Providing a list of drugs of
choice that proactively considered and incorporated patient-specific factors, allergies, and
contraindications eased the cognitive burden on the ordering clinician and may have major
implications for decreasing after-the-fact CPOE alerts and resulting alert fatigue. Clinicians could use
their working memory, concentrating on other aspects of care (such as shared decision making with
the patient to confirm or select the appropriate medication choice) rather than having to recall
medication names and doses or searching for or remembering details of a patient’s history. While
some clinicians might be expected to prefer to simply enter the drug as they usually would and resist
a shift in their electronic ordering workflow, our study found that with minimal training on the
prototype (2 minutes, compared with years of experience with their familiar EHR’s prescribing
interface), all clinicians quickly learned, adopted, and overwhelmingly preferred this new workflow.
This occurred despite the fact that the prototype was designed to preserve clinician autonomy and
flexibility to deviate from the recommended suggestions.
One noteworthy finding was the frequency with which participants accessed outside reference
materials with their usual ordering systems, and how dramatically this decreased with the prototype
system. In particular, gonorrhea and H pylori would more often require a physician to access outside
reference material for information on drugs and dosing owing to more complicated multidrug
combination therapy and evolving antibiotic resistance patterns; our system significantly reduces
this time burden in these situations. In the prototype, each of the suggested drug choices included
information (that the prescriber viewed by hovering over the choice) explaining the rationale for that
recommendation. Only rarely, when participants questioned whether they could trust the offered
prototype recommendations, did they choose to check other reference sources.
The primary motivation for our redesigned ordering system was the need to more efficiently
and effectively capture and display the indication for the prescription.24,25 By doing so, the
indications could be both communicated to the pharmacist and likely placed on the patient’s
medication bottle label. Doing so could help with patient and caregiver understanding of the
medication and thereby potentially improve medication safety through preventing medication
mix-ups and aiding adherence.7,8,26 Currently, the indication is rarely entered in the patient
instructions or displayed on the patient’s medication bottle, despite strong recommendations to do
so and a general agreement by clinicians that this would be desirable and beneficial (except in
sensitive situations such as sexually transmitted infections or mental health diagnoses).
Interviews with clinicians following the usability tests confirmed several features and concerns we
had collected in earlier design phases of this project.8 These issues and suggestions centered around
integration with the rest of the EHR and the quality and reliability of back-end knowledge required for
the drug or regimen choice recommendations. Differentiating an indication from a billing diagnosis is a
related issue that requires further conceptual and design considerations.8 In addition to defining and
maintaining the indication drug database, there are other technical and policy issues that were raised,
including challenges surrounding the generation of drug recommendations based on patient factors,
transmitting the indication information to pharmacy systems, and mapping indications to patientfriendly terms appropriate for patient medication labels and accompanying leaflets.
Generally, EHR vendors have shied away from risking legal liability by incorporating treatment
recommendations into their systems. However, several clinical content vendors have begun to create
databases linking indications with drugs, and we have been encouraged by favorable reception of
the prototype by a wide variety of participants in the drug utilization and informatics arena and have
been in discussion with EHR vendors about ways such a revamped method of ordering could be
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incorporated into their CPOE systems. This will critically depend on production of evidence-based,
trustworthy guidelines and guidance to populate recommended drug choices.

Limitations
This study has limitations. The prototype was built around only 8 scenarios. We chose scenarios to
test a broad range of typical and frequently occurring primary care prescribing issues. However, we
recognize that additional usability issues will inevitably arise when we increase the scope and
complexity of the indications and medications. Also, the fidelity of the fully functioning vendor EHRs
and our prototype CPOE system was not a direct comparison, although we attempted to ensure that
all clinical data available in the record and the point of access were the same regardless of the system.
While the pharmacists who independently reviewed the safety and appropriateness of the orders
were blinded to which system was used to generate them, the participants and observers obviously
were not blinded. This could have introduced bias in favor of the test system, although the scenarios
and request for including indication were based on evidence guidelines and recommendations to
include indications. Participants had limited training on our system vs longer lengths of training
(lengths varied, but were usually several years or more) on their usual vendor system, which should
have advantaged their speed and comfort with their vendor system.
Testing was performed in a simulated test environment. For this type of system to be successful,
maintaining other clinical data that inform the decision support is required, such as the problem list. Our
hope is that this redesigned workflow could support better integration of the problem list and ordering
system. Furthermore, our system included a feature to permit adding the problem related to the indication to the problem list with a single click, which has been shown to improve problem list maintenance.27

Conclusions
We found that a prototype built around electronically prescribing medications by indication
outperformed the electronic prescribing modules of 2 vendor EHR systems in terms of improving
efficiency and satisfaction and reducing errors in aggregate across 8 clinical scenarios. These results
suggest that there is substantial room for improvement in current applications, and that adopting
this type of approach could improve both prescriber efficiency and reduce errors, while giving
patients key information that may help with medication safety and adherence.
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